Substituted oxadiaza-spiro-(5.5)-undecanone derivatives and their use as neurokinin antagonists

Details for Australian Patent Application No. 2006222061 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Schoentjes, Bruno; Poncelet, Alain Philippe; Janssens, Frans Eduard; Coupa, Sophie

Agent Shelston IP

Pub. Number AU-B-2006222061

PCT Pub. Number WO2006/094934

Priority 05101657.4 03.03.05 EP

Filing date 3 March 2006

Wipo publication date 14 September 2006

Acceptance publication date 28 April 2011

International Classifications

C07D 498/10 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/537 (2006.01) - spiro-condensed or forming part of bridged ring systems

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

Event Publications

23 August 2007 PCT application entered the National Phase

  PCT publication WO2006/094934 Priority application(s): WO2006/094934

28 April 2011 Application Accepted

  Published as AU-B-2006222061

25 August 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006222065-Method for producing propene from propane

2006222060-Roflumilast for the treatment of diabetes mellitus